GSK Exceeded Expectations In 2022, Now Looking For Edge Over Pfizer In RSV Battle

Companies Will Reveal US Pricing Shortly

 
• By Andrew McConaghie
  
Dame Emma Walmsley
CEO Dame Emma Walmsley is hoping a renewed focus on vaccines and therapies in infectious diseases will convince investors the company is on the right track • Source: GSK
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapeutic Category